Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |